podcast about semaglutide Dr. - Our hot take on results from the #SELECT trial of (#wegovy) for those with obesity and history of heart attack or stroke on #DocsWhoLift https://podcasters.spotify.com/pod/show/docswholift Understanding NNT for Injectable Semaglutide

Later, in 2021, the FDA also approved semaglutide for weight loss under the brand name Wegovy

Specifically, participants who had lost an average of 17.3% of their body weight while on semaglutide regained about 11.6 percentage points, leaving them with only 5.6% net weight loss from baseline

Ganio says, which is where some of the unknown comes into play. Once compounders get the ingredients theyre using, theres also a bit of guesswork in terms of concocting a product that matches the brand-name version

If you do, the action of the capsules will help you in your efforts by helping you lose more weight than just dieting

Eur J Med Res 29(1):237